ATHENS, Ohio--(BUSINESS WIRE)--A team of researchers headed up by Diagnostic HYBRIDS’ Director of Monoclonal Antibody Product Development, Jimmy Page, Ph.D., and Mark Carle Connelly, Ph.D., Vice President of Reagent Development for Immunicon Corporation (NASDAQ:IMMC), has received the National Academy of Biochemistry’s Distinguished Abstract Award from the National Academy of Clinical Biochemistry for their abstract and poster presentation on an automated cell interrogation system designed to detect respiratory virus-infected cells directly in nasopharyngeal specimens from patients.
